doi.org/10.1016/j.drudis.2018.01.035
Other

Progress with covalent small-molecule kinase inhibitors

Zheng Zhao
21
,
Philip E. Bourne
58
Drug Discovery Today6.50
Volume: 23, Issue: 3, Pages: 727 - 735
Published: Mar 1, 2018
Abstract
With reduced risk of toxicity and high selectivity, covalent small-molecule kinase inhibitors (CSKIs) have emerged rapidly. Through the lens of structural system pharmacology, here we review this rapid progress by considering design strategies and the challenges and opportunities offered by current...
Paper Fields
Paper Details
Title
Progress with covalent small-molecule kinase inhibitors
DOI
doi.org/10.1016/j.drudis.2018.01.035
Published Date
Mar 1, 2018
Journal
Drug Discovery Today
Volume
23
Issue
3
Pages
727 - 735
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.